Research programme: metabolic disorder therapeutics - Healx
Latest Information Update: 28 Dec 2023
At a glance
- Originator Healx
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Barth syndrome
Highest Development Phases
- No development reported Barth syndrome
Most Recent Events
- 28 Dec 2023 No recent reports of development identified for preclinical development in Barth-syndrome in United Kingdom
- 03 Dec 2019 Research programme: metabolic disorder therapeutics - Healx is available for licensing as of 03 Dec 2019. https://healx.io/
- 21 Nov 2019 Preclinical trials in Barth syndrome in United Kingdom (unspecified route), before November 2019